![Bill Harris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
William G.
Harris worked as Finance Director at Gilead Sciences, Inc. from 1990 to 1996.
From 1996 to 2001, served as Chief Financial Officer & Senior Vice President at Coulter Pharmaceuticals, Inc. Held the position of Chief Financial Officer & Senior Vice President at Corixa Corp.
Served as Chief Financial Officer & Senior VP-Finance at XenoPort, Inc. from 2001 to 2016.
Worked as Director at Phenomix Corp.
from 2007 to 2010.
Served as Independent Director at Soleno Therapeutics, Inc. from 2014 to 2025.
Education includes undergraduate studies at the University of California San Diego and an MBA from Leavey School of Business.
Precedenti posizioni note di Bill Harris
| Società | Posizione | Fine |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/12/2025 |
| XENOPORT, INC. | Direttore Finanziario/CFO | 01/01/2016 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Direttore/Membro del Consiglio | 28/10/2010 |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Direttore Finanziario/CFO | 01/01/2001 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Direttore Finanziario/CFO | 01/01/2000 |
Formazione di Bill Harris
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leavey School of Business
 Leavey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
